Skip Navigation



Hum. Reprod. Advance Access published online on May 26, 2006
Human Reproduction, doi:10.1093/humrep/del094
This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
21/8/2033    most recent
del094v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Meriggiola, M.C.
Right arrow Articles by Pelusi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meriggiola, M.C.
Right arrow Articles by Pelusi, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received January 11, 2006
Revised February 27, 2006
Accepted March 6, 2006

Article

Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men

M.Cristina Meriggiola 1 *, S. Cerpolini 1, W.J. Bremner 2, M.T. Mbizvo 3, K.M. Vogelsong 3, G. Martorana 4, and G. Pelusi 1

1 Obstetrics and Gynecology Unit, University of Bologna and S. Orsola Hospital, Bologna, Italy
2 Department of Medicine, University of Washington, Seattle, WA, USA
3 The UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
4 Clinic of Urology, University of Bologna and S. Orsola Hospital, Bologna, Italy

* To whom correspondence should be addressed.
M.Cristina Meriggiola, E-mail: cristina.meriggiola{at}unibo.it


  Abstract

BACKGROUND: We assessed attitudes towards and acceptability of male hormonal contraception among volunteers participating in a clinical trial of a prototype regimen, consisting of progestin and testosterone injections. METHODS: After completing screening, eligible men were randomly assigned to the no-treatment group (n = 40) or to receive injections of norethisterone enanthate and testosterone undecanoate or placebo at different intervals (n = 50) according to a blocked randomization list. They underwent self-administered questionnaires. RESULTS: The average age of the participants was approximately 28 years; most were involved in a stable relationship and had no children. Ninety-two percentage of the respondents thought that men and women should share responsibility for contraception and 75% said they would try a hormonal contraceptive if available. At the end of the treatment phase, 66% of the participants said that they would use such a method, and most rated its acceptability very highly; none reported it to be unacceptable. The injections themselves were indicated as the biggest disadvantage. No significant changes in sexual function or mood states were detected among the men who underwent hormone injections. CONCLUSIONS: The contraceptive tested in this study was well accepted by the participants over the course of 1 year.

Keywords: acceptability/male hormonal contraception/testosterone.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
E. Nieschlag
Male Hormonal Contraception: Love's Labour's Lost?
J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 1890 - 1892.
[Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. T. Page, J. K. Amory, and W. J. Bremner
Advances in Male Contraception
Endocr. Rev., June 1, 2008; 29(4): 465 - 493.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
Minerva
BMJ, August 26, 2006; 333(7565): 454 - 454.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.